Aplicaciones del suero autólogo en oftalmología

  1. J.S. López-García
  2. I. García-Lozano
  3. L. Rivas
  4. J. Martínez-Garchitorena
Journal:
Archivos de la Sociedad Española de Oftalmologia

ISSN: 0365-6691

Year of publication: 2007

Volume: 82

Issue: 1

Pages: 9-20

Type: Article

DOI: 10.4321/S0365-66912007000100004 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Archivos de la Sociedad Española de Oftalmologia

Abstract

Objective: To establish a protocol for the use of autologous serum in the ophthalmic practice. Methods: Personal experience and a literature review. Results: The use of autologous serum, in eye drop form, has been reported as a new treatment for several ocular surfaces diseases. These products have biomechanical and biochemical properties similar to normal tears. They contain components such as fibronectin, vitamin A and growth factors that have an epitheliotrophic effect on the ocular surface epithelial cells. Conclusions: The clinical studies performed showed a variable efficacy, with the preparative process and use of the autologous serum eye drops varying considerably between different studies.

Bibliographic References

  • Fox, RI, Chan, R, Michelson, JB, Belmont, JB, Michelson, PE. (1984). Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum. 27. 459-461
  • Tsubota, K, Goto, E, Shimmura, S, Shimazaki, J. (1999). Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmolgy. 106. 1984-1989
  • Tsubota, K, Goto, E, Fujita, H, Ono, M, Inoue, H, Saito, I. (1999). Treatment of dry eye by autologous serum aplicattion in Sjogren`s syndrome. Br J Ophthalmol. 83. 390-395
  • Tseng, SC, Tsubota, K. (1997). Important concepts for treating ocular surface and tear disorders. Am J Ophthalmol. 124. 825-835
  • Wilson, SE, Liang, Q, Kim, WJ. (1999). Lacrimal gland HGF, KGF and EGF mRNA levels increase after corneal epithelial wounding. Invest Ophthalmol Vis Sci. 40. 2185-2190
  • Barton, K, Nava, A, Monroy, DC, Pflugfelder, SC. (1998). Cytokines and tear function in ocular surface disease. Adv Exp Med Biol. 438. 461-469
  • Geerling, G, Maclennan, S, Hartwig, D. (2004). Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. 88. 1467-1474
  • Gobbels, M, Spitznas, M. (1992). Corneal epithelial permeability of dry eyes before and after treatment with artificial tears. Ophthalmology. 99. 873-878
  • Burstein, NL. (1985). The effects of topical drugs and preservatives on the tears and corneal epithelium in dry eye. Trans Ophthalmol Soc UK. 104. 402-409
  • Geerling, G, Sieg, P, Meyer, C, Bastian, GO, Laqua, H. (1998). Transplantation of autologous submandibular glands in very severe keratoconjunctivitis sicca: 2 year outcome. Ophthalmologe. 95. 257-265
  • Vajpayee, RB, Mukerji, N, Tandon, R, Sharma, N, Pandey, RM, Biswas, NR. (2003). Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br J Ophthalmol. 87. 1312-1316
  • Borderie, VM, Mourra, N, Laroche, L. (1999). Influence of fetal calf serum, fibroblast growth factors, and hepatocyte growth factor on three-dimensional cultures of human keratocytes in collagen gel matrix. Graefes Arch Clin Exp Ophthalmol. 237. 861-869
  • Kirschner, SE. (1990). Persistent corneal ulcers: What to do when ulcers won´t heal. Vet Clin North Am Small Anim Pract. 20. 627-642
  • Alvarado Valero, MC, Martinez Toldos, JJ, Borras Blasco, J, Alminana Alminana, A, Perez Ramos, JM. (2004). Tratamiento de defectos epiteliales persistentes mediante suero autólogo. Arch Soc Esp Oftalmol. 79. 537-542
  • Kruse, FE, Tseng, SC. (1993). Serum differentially modulates the clonal growth and differentiation of cultured limbal and corneal epithelium. Invest Ophthalmol Vis Sci. 34. 2976-2989
  • van Setten, GB, Tervo, T, Tervo, K, Tarkkanen, A. (1992). Epidermal growth factor (EGF) in ocular fluids: presence, origin and therapeutical considerations. Acta Ophthalmol Suppl. 202. 54-59
  • Pastor, JC, Calonge, M. (1992). Epidermal growth factor and corneal wound healing: A multicenter study. Cornea. 11. 311-314
  • Collins, MK, Perkins, GR, Rodriguez-Tarduchy, G, Nieto, MA, Lopez-Rivas, A. (1994). Growth factors as survival factors: regulation of apoptosis. Bioessays. 16. 133-138
  • Rodeck, U, Jost, M, Kari, C, Shih, DT, Lavker, RM, Ewert, DL. (1997). EGF-R dependent regulation of keratinocyte survival. J Cell Sci. 110. 113-121
  • Ohashi, Y, Motokura, M, Kinoshita, Y, Mano, T, Watanabe, H, Kinoshita, S. (1989). Presence of epidermal growth factor in human tears. Invest Ophthalmol Vis Sci. 30. 1879-1882
  • Gupta, A, Monroy, D, Ji, Z, Yoshino, K, Huang, A, Pflugfelder, SC. (1996). Transforming growth factor beta-1 and beta-2 in human tear fluid. Curr Eye Res. 15. 605-614
  • Fredj-Reygrobellet, D, Plouet, J, Delayre, T, Baudouin, C, Bourret, F, Lapalus, P. (1987). Effects of aFGF and bFGF on wound healing in rabbit corneas. Curr Eye Res. 6. 1205-1209
  • Yoshino, K, Garg, R, Monroy, D, Ji, Z, Pflugfelder, SC. (1996). Production and secretion of transforming growth factor beta (TGF-beta) by the human lacrimal gland. Curr Eye Res. 15. 615-624
  • Wilson, SE, Lloyd, SA, Kennedy, RH. (1991). Basic fibroblast growth factor (FGFb) and epidermal growth factor (EGF) receptor messenger RNA production in human lacrimal gland. Invest Ophthalmol Vis Sci. 32. 2816-2820
  • Shimmura, S, Ueno, R, Matsumoto, Y, Goto, E, Higuchi, A, Shimazaki, J. (2003). Albumin as a tear supplement in the treatment of severe dry eye. Br J Ophthalmol. 87. 1279-1283
  • Poon, AC, Geerling, G, Dart, JK, Fraenkel, GE, Daniels, JT. (2001). Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol. 85. 1188-1197
  • Nishida, T, Ohashi, Y, Awata, T, Manabe, R. (1983). Fibronectin: A new therapy for corneal trophic ulcer. Arch Ophthalmol. 101. 1046-1048
  • Phan, TM, Foster, CS, Shaw, CD, Zagachin, LM, Colvin, RB. (1991). Topical fibronectin in an alkali burn model of corenal ulceration in rabbits. Arch Ophthalmol. 109. 414-419
  • Nishida, T, Nakamura, M, Ofuji, K, Reid, TW, Mannis, MJ, Murphy, CJ. (1996). Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea. J Cell Physiol. 169. 159-166
  • Lagnado, R, King, AJ, Donald, F, Dua, HS. (2004). A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders. Br J Ophthalmol. 88. 464-465
  • Tananuvat, N, Daniell, M, Sullivan, LJ, Yi, Q, McKelvie, P, McCarty, DJ. (2001). Controlled study of the use of autologous serum in dry eye patients. Cornea. 20. 802-806
  • Malavazzi, GR, Lake, JC, Dantas, PE. (2005). Effect of honey and autologous serum on corneal epithelial healing in rabbits. Arq Bras Oftalmol. 68. 347-351
  • Noble, BA, Loh, RS, MacLennan, S, Pesudovs, K, Reynols, A, Bridges, LR. (2004). Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol. 88. 647-652
  • Pasternak, AS, Miller, WM. (1995). First-order toxicity assays for eye irritation using cell lines: parameters that affect in vitro evaluation. Fundam Appl Toxicol. 25. 253-263
  • Wang, XM, Terasaki, PI, Rankin, GW jr, Chia, D, Zhong, HP, Haardy, S. (1993). A new microcellular cytotoxicity test based on calcein AM release. Hum Immunol. 37. 264-270
  • Geerling, G, Daniels, JT, Dart, JK, Cree, IA, Khaw, PT. (2001). Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells. Invest Ophthalmol Vis Sci. 42. 948-956
  • You, L, Ebner, S, Kruse, FE. (2001). Glial cell-derived neurotrophic factor (GDNF)-induced migration and signal transduction in corneal epithelial cells. Invest Ophthalmol Vis Sci. 42. 2496-2504
  • Voak, D, Cann, R, Finney, RD, Fraser, ID, Mitchell, R, Murphy, MF. (1994). Guidelines for administration of blood products: transfusion of infants and neonates. Transfus Med. 4. 63-69
  • Liu, L, Hartwig, D, Harloff, S, Herminghaus, P, Wedel, T, Geerling, G. (2005). An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol. 243. 706-714
  • Garcia Jimenez, V, Veiga Villaverde, B, Baamonde Arbaiza, B, Cahue Carpintero, I, Celemin Vinuela, ML, Simo Martinez, RM. (2003). The elaboration, use and evaluation of eye-drops with autologous serum in corneal lesions. Farm Hosp. 27. 21-25
  • Sitaramamma, T, Shivaji, S, Rao, GN. (1998). Effect of storage on protein concentration of tear samples. Curr Eye Res. 17. 1027-1035
  • Mukerji, N, Sinha, R, Vajpayee, RB. (2002). Role of autologous serum in persistent epithelial defects. Br J Ophthalmol. 86. 832
  • Sauer, R, Bluthner, K, Seitz, B. (2004). Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects. Ophthalmologe. 101. 705-709
  • Nakamura, M, Nishida, T, Mishima, H, Otori, T. (1993). Effects of antimicrobials on corneal epithelial migration. Curr Eye Res. 12. 733-740
  • Young, AL, Cheng, AC, Ng, HK, Cheng, LL, Leung, GY, Lam, DS. (2004). The use of autologuos serum tears in persistent corneal epithelial defects. Eye. 18. 609-614
  • Pfister, RR. (1992). Clinical measures to promote corneal epithelial healing. Acta Ophthalmol Suppl. 202. 73-83
  • Ali, Z, Insler, MS. (1986). A comparison of therapeutic bandage lenses, tarsorrhaphy, and antibiotic and hypertonic saline on corneal epithelial wound healing. Ann Ophthalmol. 18. 22-24
  • Panda, A, Pushker, Bageshwar, LM. (1999). Lateral tarsorrhaphy: is it preferable to patching?. Cornea. 18. 299-301
  • Azuara-Blanco, A, Pillai, CT, Dua, HS. (1999). Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol. 83. 399-402
  • Tan, DT, Ficker, LA, Buckley, RJ. (1996). Limbal transplantation. Ophthalmology. 103. 29-36
  • Gordon, JF, Johnson, P, Musch, DC. (1995). Topical fibronectin ophthalmic solution in the treatment of persistent defects of the corneal epithelium. Am J Ophthalmol. 119. 281-287
  • Ralph, RA. (2000). Tetracyclines and the treatment of corneal stromal ulceration: a review. Cornea. 19. 274-277
  • Pellegrini, G, Traverso, CE, Franzi, AT, Zingirian, M, Cancedda, R, De Luca, M. (1997). Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet. 349. 990-993
  • Díaz-Valle, D, Benítez del Castillo Sánchez, JM, Díaz Rodríguez, E, Toledano Fernández, N, Arteaga Sánchez, A, Sayagues Gómez, O. (2003). Manejo de la queratopatía neurotrófica mediante tarsorrafia con cianoacrilato y suero autólogo. Arch Soc Esp Oftalmol. 78. 119-122
  • Matsumoto, Y, Dogru, M, Goto, E, Ohashi, Y, Kojima, T, Ishida, R, Tsubota, K. (2004). Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology. 111. 1115-1120
  • del Castillo, JM, de la Casa, JM, Sardina, RC, Fernandez, RM, Feijoo, JG, Gomez, AC. (2002). Treatment of recurrent corneal erosions using autologous serum. Cornea. 21. 781-783
  • Tsubota, K, Satake, Y, Ohyama, M, Toda, I, Takano, Y, Ono, M. (1996). Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol. 122. 38-52
  • Ogawa, Y, Okamoto, S, Mori, T, Yamada, M, Mashima, Y, Watanabe, R. (2003). Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant. 31. 579-583
  • Rocha, EM, Pelegrino, FS, de Paiva, CS, Vigorito, AC, de Souza, CA. (2000). GVDH dry eyes treated with autologous serum tears. Bone Marrow Transplant. 25. 1101-1103
  • Goto, E, Shimmura, S, Shimazaki, J, Tsubota, K. (2001). Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea. 20. 807-810
  • Matsuo, H, Tomidokoro, A, Tomita, G, Araie, M. (2005). Topical application of autologous serum for the treatment of late-onset aqueous oozing or point-leak through filtering bleb. Eye. 19. 23-28
  • Liggett, PE, Skolik, DS, Horio, B, Saito, Y, Alfaro, V, Mieler, W. (1995). Human autologous serum for the treatment of full-thickness macular holes. A preliminary study. Ophthalmology. 102. 1071-1076
  • Nakamura, H, Hayakawa, K, Sawaguchi, S, Gaja, T. (2005). Removal of retinal indocyanine green dye by autologous serum irrigation in macular hole surgery. Retina. 25. 736-741
  • Christmas, NJ, Skolik, SA, Howard, MA, Saito, Y, Barnstable, CJ, Liggett, PE. (1995). Treatment of retinal breaks with autologous serum in an experimental model. Ophthalmology. 102. 263-271
  • Cullinane, AB, O´Callaghan, P, McDermott, K, Keohane, C, Cleary, PE. (2002). Effects of autologous platelet concentrate and serum on retinal wound healing in an animal model. Graefes Arch Clin Exp Ophthalmol. 240. 35-41
  • McDonnell, PJ, Schanzlin, DJ, Rao, NA. (1988). Immunoglobulin deposition in the cornea after application of autologous serum. Arch Ophthalmol. 106. 1423-1425
  • Eberle, J, Habermann, J, Gurtler, LG. (2000). HIV-1 infection transmitted by serum droplets into the eye: a case report. AIDS. 14. 206-207
  • Yokoi, N, Komuro, A, Nishida, K, Kinoshita, S. (1997). Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye. Br J Ophthalmol. 81. 533-536
  • Nelson, JD, Drake, MM, Brewer, JT Jr, Tuley, M. (1994). Evaluation of a physiological tear substitute in patients with keratoconjunctivitis sicca. Adv Exp Med Biol. 350. 453-457
  • Nelson, JD, Gordon, JF. (1992). Topical fibronectin in the treatment of keratoconjunctivitis sicca. Am J Ophthalmol. 114. 441-447
Data source: Dialnet